P-135 Effects of venlafaxine on clinical and pupillometry measures in patients with progressive supranuclear palsy. (April 2023) - Zeitzschel, M.; Maheu, M.; Donner, T.; Gerloff, C.; Moll, C.; Gulberti, A.; Pötter-Nerger, M.